Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Beginning Cash Balance: 2009-2024

Historic Beginning Cash Balance for Sunshine Biopharma (SBFM) over the last 16 years, with Dec 2024 value amounting to $15.2 million.

  • Sunshine Biopharma's Beginning Cash Balance fell 17.94% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 38.18%. This contributed to the annual value of $15.2 million for FY2024, which is 31.61% down from last year.
  • According to the latest figures from FY2024, Sunshine Biopharma's Beginning Cash Balance is $15.2 million, which was down 31.61% from $22.3 million recorded in FY2023.
  • Sunshine Biopharma's Beginning Cash Balance's 5-year high stood at $22.3 million during FY2023, with a 5-year trough of $40,125 in FY2020.
  • In the last 3 years, Sunshine Biopharma's Beginning Cash Balance had a median value of $15.2 million in 2024 and averaged $13.3 million.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first slumped by 63.30% in 2020, then surged by 2,316.50% in 2021.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Beginning Cash Balance stood at $40,125 in 2020, then skyrocketed by 2,316.50% to $969,620 in 2021, then skyrocketed by 129.89% to $2.2 million in 2022, then soared by 900.32% to $22.3 million in 2023, then slumped by 31.61% to $15.2 million in 2024.